|
Sign In to gain access to subscriptions and/or personal tools.
|
Point-of-Care Platelet Function Testing
Christopher C. Harle, MBChB, FRCA
Department of Anesthesia and Perioperative Medicine, London Health Sciences Centre, University of Western Ontario, London, Ontario, Canada, Christopher.Harle{at}hsc.on.ca
Cardiopulmonary bypass has unpredictably deleterious effects on platelet function. Patients with cardiovascular disease have treatments aimed at reducing platelet aggregation and are at risk of excessive bleeding during surgery. Transfusion of blood products, particularly platelets, probably causes increased morbidity and mortality. Conversely, patients with excessive platelet aggregation are at risk of thrombotic complications—undesirable outcomes in the context of myocardial revascularization and prevention of stroke. Platelet function is difficult to monitor. Laboratory tests take time, and the results are not immediately available. Point-of-care (POC) testing of platelet function should facilitate the clinical management of bleeding patients by rationalizing platelet transfusion and avoiding unnecessary transfusion. Furthermore, POC platelet function could alert the clinician to risks of excessive platelet activation and measure the efficacy of antiplatelet therapy. This article outlines some of the POC platelet function monitors available as well as their potential applications.
Key Words: platelet function • point-of-care monitoring • hemostasis • thrombosis
References
- Tran H., Anand SS Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease. JAMA. 2004;292:1867-1874.[Abstract/Free Full Text]
- Mobley JE, Bresee SJ, Wortham DC, Craft RM, Snider CC, Carroll RC Frequency of nonresponse antiplatelet activity of clopidogrel during pretreatment for cardiac catheterization. Am J Cardiol. 2004;93:456-458.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Spiess BD Transfusion of blood products affects outcome in cardiac surgery. Semin Cardiothorac Vasc Anesth. 2004; 8:267-281.[Abstract/Free Full Text]
- Vamvakas EC Platelet transfusion and adverse outcomes. Lancet. 2004;364:1736-1738.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Karkouti K., Wijeysundera DN, Yau TM, et al. Platelet transfusions are not associated with increased morbidity or mortality in cardiac surgery. Can J Anaesth. 2006; 53:279-287.[Web of Science][Medline]
[Order article via Infotrieve]
- Shore-Lesserson L., Manspeizer HE, DePerio M., Francis S., Vela-Cantos F., Ergin MA Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg. 1999;88:312-319.[Abstract/Free Full Text]
- Parise LV, Smyth SS, Shet AS, Coller BS Platelet morphology, biochemistry, and function. In: Lichtman MA, Beutler E, Kaushansky K, Kipps TJ, Seligsohn U, Prchal J, eds. Williams Hematology. 7th ed. New York, NY: McGraw-Hill.
- Pamukcu B. A review of aspirin resistance; definition, possible mechanisms, detection with platelet function tests, and its clinical outcomes. J Thromb Thrombolysis. 2007;23:213-222.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Michelson AD Flow cytometry: a clinical test of platelet function. Blood. 1996;87:4925-4936.[Free Full Text]
- Sie P., Steib A. Central laboratory and point of care assessment of perioperative hemostasis. Can J Anaesth. 2006;53:S12-S20.[Web of Science][Medline]
[Order article via Infotrieve]
- Jilma B. Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction. J Lab Clin Med. 2001;138:152-163.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Paniccia R., Antonucci E., Gori AM, et al. Different methodologies for evaluating the effect of clopidogrel on platelet function in high-risk coronary artery disease patients. J Thromb Haemost. 2007;5:1839-1847.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- McKenzie ME, Gurbel PA, Levine DJ, Serebruany VL Clinical utility of available methods for determining platelet function. Cardiology. 1999;92:240-247.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Smith JW, Steinhubl SR, Lincoff AM, et al. Rapid platelet-function assay: an automated and quantitative cartridge-based method. Circulation. 1999;99:620-625.[Abstract/Free Full Text]
- Mallett SV, Cox DJ Thrombelastography. Br J Anaesth. 1992;69:307-313.[Free Full Text]
- Hobson AR, Agarwala RA, Swallow RA, Dawkins KD, Curzen NP Thrombelastography: current clinical applications and its potential role in interventional cardiology. Platelets. 2006;17:509-518.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Nicholson NS, Panzer-Knodle SG, Haas NF, et al. Assessment of platelet function assays. Am Heart J. 1998;135:S170-S178.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Craft RM, Chavez JJ, Snider CC, Muenchen RA, Carroll RC Comparison of modified Thrombelastograph and Plateletworks whole blood assays to optical platelet aggregation for monitoring reversal of clopidogrel inhibition in elective surgery patients. J Lab Clin Med. 2005;145:309-315.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Michelson AD, Frelinger AL III, Furman MI Current options in platelet function testing. Am J Cardiol. 2006;98:S4-S10.[CrossRef]
- Lau WC, Waskell LA, Watkins PB, et al. Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interaction. Circulation. 2003;107:32-37.[Abstract/Free Full Text]
- Savion N., Varon D. Impact—the cone and plate(let) analyzer: testing platelet function and anti-platelet drug response. Pathophysiol Haemost Thromb. 2006;35:83-88.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
Seminars in Cardiothoracic and Vascular Anesthesia, Vol. 11, No. 4,
247-251 (2007)
DOI: 10.1177/1089253207311153
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
|
|
